Population
Cancer patients at risk for or with venous thromboembolism
Design
Review
Authors
Loading...
May support risk-stratified thromboprophylaxis in cancer; leaves open prospective validation of tools.
This review highlights the multifactorial pathogenesis of VTE in cancer patients and emphasizes the need for risk stratification to balance thromboprophylaxis efficacy with bleeding risks.
Galila Zaher (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: